These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 20713858)
1. Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in a patient with refractory GI graft-versus-host disease. Gergis U; Arnason J; Yantiss R; Shore T; Wissa U; Feldman E; Woodworth T J Clin Oncol; 2010 Oct; 28(30):e602-4. PubMed ID: 20713858 [No Abstract] [Full Text] [Related]
2. Successful use of Campath-1H in the treatment of steroid refractory liver GvHD. Wandroo F; Auguston B; Cook M; Craddock C; Mahendra P Bone Marrow Transplant; 2004 Aug; 34(3):285-7. PubMed ID: 15170160 [No Abstract] [Full Text] [Related]
3. Effective use of tocilizumab for the treatment of steroid-refractory gastrointestinal acute graft versus host disease in a child with very high levels of serum interleukin-6. Kolb M; Bhatia M; Madina GG; Satwani P Pediatr Blood Cancer; 2015 Feb; 62(2):362-363. PubMed ID: 25212196 [TBL] [Abstract][Full Text] [Related]
6. Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients. Tao T; Ma X; Yang J; Zou JY; Ji SM; Tan YS; Gong W; Du F; Xu J; Ye CM; Tang XW; Wu DP; Xue SL Blood Cancer J; 2015 Apr; 5(4):e308. PubMed ID: 25885428 [No Abstract] [Full Text] [Related]
15. [Clinical study on recombinant humanized anti-CD25 monoclonal antibody used for treating steroid-resistant acute graft versus host disease following allo-hematopoietic stem cell transplantation]. Li XH; Gao CJ; DA WM; Cao YB; Xu LX; Wu YM; Liu B; Liu ZY; Yan B; Li SW; Yang XL; Wu XX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1535-40. PubMed ID: 24370044 [TBL] [Abstract][Full Text] [Related]
16. Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis. Inoue D; Arima H; Kawanami C; Takiuchi Y; Nagano S; Kimura T; Shimoji S; Mori M; Tabata S; Yanagita S; Matsushita A; Nagai K; Imai Y; Takahashi T Clin Rheumatol; 2010 Oct; 29(10):1195-7. PubMed ID: 20229259 [TBL] [Abstract][Full Text] [Related]
18. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Canninga-van Dijk MR; van der Straaten HM; Fijnheer R; Sanders CJ; van den Tweel JG; Verdonck LF Blood; 2004 Oct; 104(8):2603-6. PubMed ID: 15251978 [TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab. von Bonin M; Oelschlägel U; Radke J; Stewart M; Ehninger G; Bornhauser M; Platzbecker U Transplantation; 2008 Sep; 86(6):875-9. PubMed ID: 18813113 [TBL] [Abstract][Full Text] [Related]
20. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival. Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]